ASX - By Stock
|
NEU |
Re:
Share Price
|
|
TripAces
|
9.8K |
4.3M |
19 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
9.8K
|
4.3M
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
15 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
418
|
184K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Upcoming Phase 2 Trial Announcement Dates
|
|
TripAces
|
7 |
3.7K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
7
|
3.7K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
TripAces
|
130 |
61K |
18 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
130
|
61K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
TripAces
|
130 |
61K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
130
|
61K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
TripAces
|
130 |
61K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
130
|
61K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
946
|
469K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
946
|
469K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
418
|
184K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
TripAces
|
316 |
158K |
3 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
316
|
158K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
3 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
418
|
184K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
TripAces
|
316 |
158K |
3 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
158K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
5 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
418
|
184K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
TripAces
|
9.8K |
4.3M |
5 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
9.8K
|
4.3M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
TripAces
|
9.8K |
4.3M |
28 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
9.8K
|
4.3M
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
23 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
418
|
184K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
TripAces
|
107 |
61K |
7 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
107
|
61K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
TripAces
|
9.8K |
4.3M |
21 |
28/01/24 |
28/01/24 |
ASX - By Stock
|
9.8K
|
4.3M
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
6 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
418
|
184K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
16 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
418
|
184K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Jefferies Role
|
|
TripAces
|
9 |
4.2K |
29 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
9
|
4.2K
|
29
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
16 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
946
|
469K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
2 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
946
|
469K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
9 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
946
|
469K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
23 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
946
|
469K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
14 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
946
|
469K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
The NDD box seat
|
|
TripAces
|
13 |
9.1K |
21 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
13
|
9.1K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
TripAces
|
121 |
52K |
6 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
121
|
52K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
TripAces
|
121 |
52K |
24 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
121
|
52K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
TripAces
|
121 |
52K |
22 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
121
|
52K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
TripAces
|
121 |
52K |
14 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
121
|
52K
|
14
|
|
ASX - By Stock
|
EUR |
Re:
Ann: NASDAQ Listing Update
|
|
TripAces
|
159 |
46K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
159
|
46K
|
0
|
|
ASX - By Stock
|
EUR |
Re:
Ann: NASDAQ Listing Update
|
|
TripAces
|
159 |
46K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
159
|
46K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
418 |
184K |
23 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
418
|
184K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
10 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
946
|
469K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: P2 trial shows significant improvements in Phelan-McDermid
|
|
TripAces
|
208 |
84K |
10 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
208
|
84K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
TripAces
|
315 |
155K |
12 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
315
|
155K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
TripAces
|
315 |
155K |
8 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
315
|
155K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
TripAces
|
9.8K |
4.3M |
2 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
9.8K
|
4.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
TripAces
|
677 |
320K |
12 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
677
|
320K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
13 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
946
|
469K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
TripAces
|
87 |
38K |
11 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
87
|
38K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
$20 party
|
|
TripAces
|
73 |
31K |
24 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
73
|
31K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
TripAces
|
248 |
105K |
14 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
248
|
105K
|
14
|
|
ASX - By Stock
|
RMY |
Re:
Ann: Chair & CEO Address to Shareholders
|
|
TripAces
|
6 |
1.6K |
8 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
6
|
1.6K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
TripAces
|
248 |
105K |
11 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
248
|
105K
|
11
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
TripAces
|
248 |
105K |
4 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
248
|
105K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
the game is ON
|
|
TripAces
|
123 |
61K |
21 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
123
|
61K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
TripAces
|
9.8K |
4.3M |
2 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
9.8K
|
4.3M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
TripAces
|
946 |
469K |
30 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
946
|
469K
|
30
|
|